REED JOHN C - Insider Non-Derivative Transactions at JOHNSON & JOHNSON (JNJ) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Oct 17, 2025, REED JOHN C's relationship to JOHNSON & JOHNSON (JNJ) is Officer (EVP, Innovative Medicine, R&D), and currently has 32,379 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other JNJ insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

REED JOHN C - Insider Non-Derivative Transactions of JNJ Common Stock

REED JOHN C - Insider Non-Derivative Transactions at JNJ

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 18, 2025	Sell -- (Common Stock)	21721	192.71	10658
Oct 18, 2025	M -- (Common Stock)	21721	157.92	32379
Jul 18, 2025	Sell -- (Common Stock)	19137	163.55	10658
May 2, 2025	F -- (Common Stock)	11002	156.31	29795
May 2, 2025	M -- (Common Stock)	25255	0	40797
Feb 19, 2025	F -- (Common Stock)	385	156.15	15542
Feb 16, 2025	M -- (Common Stock)	1350	0	15927
May 2, 2024	F -- (Common Stock)	10984	144.59	11577
May 2, 2024	F -- (Common Stock)	10984	144.59	14577
May 2, 2024	M -- (Common Stock)	22255	0	22561
May 2, 2024	M -- (Common Stock)	25255	0	25561